Joseph I. Bower is Director at Anika Therapeutics, Inc. (ANIK). They have made 1 open-market trade across 1 company since 2016, most recently 2019-02-26.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIK | SELL | 2016-11-09 | 2016-11-09 | $43.39 | $23K | +4.0% | +12.2% | +13.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.